Grad Zagreb

Croatia

203 total trials 79 recruiting

Filter these 203 trials by phase, condition, sponsor and more.

Open in Search →

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended

2023-504991-31-00 5 2021-05-06 Agitation in Patients With Dementia of the Alzheimer's Type
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor tolebrutinib (SAR442168) (PERSEUS) Ended

2024-514495-41-00 5 2020-11-04 Primary Progressive Multiple Sclerosis
A Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax alone or in Combination with Ruxolitinib in Subjects with Myelofibrosi … Ended

2023-507276-53-00 4 2020-03-23 Myelofibrosis
A study to learn about the effects and safety of obeticholic acid in combination with bezafibrate in participants with primary biliary chola … Ended

2024-513762-18-00 4 2019-09-20 Primary Biliary Cholangitis (PBC)
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema) – Measure Up 2 Ended

2022-502936-38-00 5 2019-01-09 Moderate and Severe Atopic Dermatitis
Evaluation of Upadacitinib in Adolescent and Adult Patients with Moderate to Severe Atopic Dermatitis (Eczema)– Measure Up 1 Ended

2022-502938-30-00 5 2018-12-10 Moderate and Severe Atopic Dermatitis
Effectiveness and Safety of Sparsentan as treatment for Primary Focal Segmental Glomerulosclerosis (FSGS) Ended

2023-505494-32-00 5 2018-10-15 Focal segmental glomerulosclerosis (FSGS)
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn's Disease Ended

2024-511553-22-00 5 2018-10-05 Moderately to Severely Active Crohn's Disease
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn's Disease Ended

2023-510426-33-00 5 2018-09-27 Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in A F. Hoffmann-la … Ended

2023-506543-41-00 5 2018-07-25 Multiple sclerosis (MS)
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and … Ended

2023-504034-22-00 5 2014-12-18 Chronic Lymphocytic Leukemia (CLL)

Showing 193–203 of 203 trials